Dr. Pollock has a lifetime professional dedication to patient care and research in soft tissue sarcoma. His clinical practice focuses exclusively on this disease entity, and he has pursued clinical and laboratory research interests in soft tissue sarcoma during the entire time that he has been a member of the faculty of the Department of Surgical Oncology. Currently Dr. Pollock provides leadership for the Sarcoma Research Center at The University of Texas M. D. Anderson Cancer Center. His laboratory research interests include molecular-oriented tissue- and cell line-based investigations focusing on the role of the p53 tumor suppressor gene in soft tissue sarcoma, modulation of angiogenesis in soft tissue sarcoma, mechanisms of soft tissue sarcoma chemoresistance, as well as the development of novel therapeutics for this disease. Dr. Pollock is the incumbent in the Senator A.M. Aiken, Jr., Distinguished Chair, and holds joint appointments in the Department of Molecular and Cellular Oncology at The University of Texas M. D. Anderson Cancer and the Department of Surgery at The University of Texas Health Sciences Center/ Houston. Copyright © 2012 Liddy Shriver Sarcoma Initiative. |